Physician profile
Son M Le
NPI 1174655054
$2,680.69
in general payments reported to CMS, 2019-2025
10 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $455 · 2023: $304 · 2024: $94.75 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,129 · Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,128.89 |
| Food and Beverage | $749.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,432.25 | 2022-2025 | |
| Abbott Laboratories | $549.33 | 2021-2023 | Proclaim |
| Globus Medical, INC. | $251.80 | 2021-2025 | Creo 5.5, Excelsius3d Imaging System, Senza |
| Bayer Healthcare Pharmaceuticals INC. | $141.31 | 2025 | |
| Medtronic, INC. | $88.73 | 2022-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Inceptiv |
| Genentech USA, INC. | $75.03 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $64.49 | 2023 | Eliquis |
| Cerapedics INC. | $37.05 | 2021 | |
| Novo Nordisk INC | $25.00 | 2023 | |
| Merck Sharp & Dohme LLC | $15.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Son Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.